Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 19 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 590006 | NSE: AMRUTANJAN

Amrutanjan Health Care Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 19, 2024, 7:29 pm

Market Cap 2,090 Cr.
Current Price 724
High / Low863/556
Stock P/E44.0
Book Value 103
Dividend Yield0.64 %
ROCE21.3 %
ROE15.5 %
Face Value 1.00
PEG Ratio-6.49

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Amrutanjan Health Care Ltd

Competitors of Amrutanjan Health Care Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Gujarat Themis Biosyn Ltd 3,574 Cr. 328390/10867.8 20.50.20 %45.0 %33.8 % 1.00
Gujarat Terce Laboratories Ltd 61.0 Cr. 82.294.9/25.823.4 11.90.00 %9.72 %3.44 % 10.0
Gujarat Inject (Kerala) Ltd 28.0 Cr. 19.119.5/8.3536.3 6.640.00 %4.06 %3.33 % 10.0
Godavari Drugs Ltd 86.3 Cr. 115155/87.012.9 55.40.00 %12.7 %15.5 % 10.0
Glenmark Life Sciences Ltd 13,185 Cr. 1,0771,335/62031.1 2072.09 %28.1 %21.1 % 2.00
Industry Average15,044.04N/A43.90N/AN/A16.2516.45N/A

All Competitor Stocks of Amrutanjan Health Care Ltd

Quarterly Result

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales78.21110.38110.70106.5570.95110.7297.65100.3277.8699.31116.99127.0683.74
Expenses63.6687.4485.0890.2067.6294.7985.4987.3470.7192.4795.42110.8280.19
Operating Profit14.5522.9425.6216.353.3315.9312.1612.987.156.8421.5716.243.55
OPM %18.60%20.78%23.14%15.34%4.69%14.39%12.45%12.94%9.18%6.89%18.44%12.78%4.24%
Other Income2.744.293.205.163.013.033.684.823.693.953.764.954.45
Interest0.080.070.030.300.020.020.020.020.020.030.050.050.06
Depreciation0.920.800.881.191.071.521.311.311.391.551.581.531.59
Profit before tax16.2926.3627.9120.025.2517.4214.5116.479.439.2123.7019.616.35
Tax %25.97%24.70%26.30%26.52%30.29%26.75%26.12%22.95%25.56%25.62%26.41%30.34%27.24%
Net Profit12.0619.8520.5814.713.6612.7710.7112.707.016.8517.4513.664.62
EPS in Rs4.136.797.045.031.254.373.664.342.402.376.044.721.60

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales128131154174207220253261333406380421427
Expenses109108130143178192222231258326335369379
Operating Profit19232532292831317580455248
OPM %15%18%16%18%14%13%12%12%22%20%12%12%11%
Other Income435678781115151617
Interest2210000011000
Depreciation3323233444566
Profit before tax18212635343335348291546259
Tax %32%32%35%35%35%39%29%27%25%26%26%27%
Net Profit12151722222025256167404543
EPS in Rs4.154.975.867.687.476.848.398.5820.9322.9913.6315.5514.73
Dividend Payout %36%32%30%25%26%22%26%24%20%20%34%30%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)25.00%13.33%29.41%0.00%-9.09%25.00%0.00%144.00%9.84%-40.30%12.50%
Change in YoY Net Profit Growth (%)0.00%-11.67%16.08%-29.41%-9.09%34.09%-25.00%144.00%-134.16%-50.13%52.80%

Amrutanjan Health Care Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:12%
5 Years:11%
3 Years:8%
TTM:17%
Compounded Profit Growth
10 Years:11%
5 Years:13%
3 Years:-10%
TTM:28%
Stock Price CAGR
10 Years:13%
5 Years:10%
3 Years:-8%
1 Year:19%
Return on Equity
10 Years:20%
5 Years:21%
3 Years:19%
Last Year:15%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:43 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital3333333333333
Reserves8594102118113126143156213262288286295
Borrowings13600200211122
Other Liabilities26222528343842445784707783
Total Liabilities127124130149152166188205274350362367383
Fixed Assets17151322272826262328495051
CWIP11411000217121
Investments3014141010818181813500
Other Assets7995100116115131144161232291307315331
Total Assets127124130149152166188205274350362367383

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +8181921819211891522028
Cash from Investing Activity +1616-51-0-8-11-14-88-36-219
Cash from Financing Activity +-17-14-12-11-5-9-7-12-7-17-15-48
Net Cash Flow820212323-7-4-13-1

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow6.0017.0025.0032.0027.0028.0031.0029.0074.0079.0044.0050.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days786662555146473719343242
Inventory Days444544444440457445535850
Days Payable5544465111010292981061229596
Cash Conversion Cycle67676148-15-16013-41-35-6-5
Working Capital Days57544245802630712992117173
ROCE %20%24%26%29%28%25%25%23%44%38%19%21%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters50.02%50.02%50.02%50.02%50.02%50.02%50.03%50.03%50.59%50.59%50.59%50.58%
FIIs1.53%1.83%1.43%1.42%0.87%0.76%0.68%0.69%0.75%0.80%1.38%1.55%
DIIs6.94%6.14%6.14%6.16%6.30%6.39%7.18%7.22%7.10%7.24%7.29%7.32%
Public41.41%41.90%42.23%42.21%42.62%42.65%41.93%41.87%41.39%41.19%40.66%40.47%
Others0.10%0.11%0.18%0.18%0.18%0.18%0.18%0.18%0.18%0.18%0.07%0.07%
No. of Shareholders41,64061,36767,32366,17371,06472,10469,94771,42872,00268,40462,66457,169

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
DSP Small Cap Fund1,466,2690.69110.79484,5382024-11-16202.61%
Sundaram Small Cap Fund484,5381.0736.61484,5382024-11-160%
ICICI Prudential FMCG Fund - Dividend34,7720.152.63484,5382024-11-16-92.82%
ICICI Prudential FMCG Fund - Growth34,7720.152.63484,5382024-11-16-92.82%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 17Mar 16Mar 15Mar 14Mar 13
FaceValue2.002.002.002.002.00
Basic EPS (Rs.)14.4714.0810.318.516.92
Diluted EPS (Rs.)14.4714.0810.318.516.92
Cash EPS (Rs.)16.4316.3712.5110.989.47
Book Value[Excl.RevalReserv]/Share (Rs.)86.2274.4064.9761.0656.29
Book Value[Incl.RevalReserv]/Share (Rs.)86.2274.4064.9761.0656.29
Revenue From Operations / Share (Rs.)153.25127.77113.9796.9794.18
PBDIT / Share (Rs.)23.1624.9519.3216.9314.83
PBIT / Share (Rs.)21.2022.6617.1314.4712.28
PBT / Share (Rs.)22.7522.3616.6413.2610.59
Net Profit / Share (Rs.)14.4714.0810.318.516.92
NP After MI And SOA / Share (Rs.)14.4714.0810.318.516.92
PBDIT Margin (%)15.1119.5216.9517.4615.75
PBIT Margin (%)13.8317.7315.0214.9213.04
PBT Margin (%)14.8417.5014.6013.6711.24
Net Profit Margin (%)9.4311.019.048.787.34
NP After MI And SOA Margin (%)9.4311.019.048.787.34
Return on Networth / Equity (%)16.7718.9215.8713.9412.29
Return on Capital Employeed (%)23.8729.4525.5222.7320.83
Return On Assets (%)13.0714.6512.1610.348.14
Total Debt / Equity (X)0.010.020.020.080.18
Asset Turnover Ratio (%)1.481.351.301.121.00
Current Ratio (X)3.463.593.202.871.67
Quick Ratio (X)3.153.272.872.551.40
Inventory Turnover Ratio (X)7.677.096.936.065.44
Dividend Payout Ratio (NP) (%)0.0027.3433.9337.5843.33
Dividend Payout Ratio (CP) (%)0.0023.5227.9729.1431.67
Earning Retention Ratio (%)0.0072.6666.0762.4256.67
Cash Earning Retention Ratio (%)0.0076.4872.0370.8668.33
Interest Coverage Ratio (X)78.7283.4739.7214.018.75
Interest Coverage Ratio (Post Tax) (X)43.9148.1022.208.055.08
Enterprise Value (Cr.)817.64564.15663.81156.21169.76
EV / Net Operating Revenue (X)3.653.023.991.101.23
EV / EBITDA (X)24.1615.4723.516.317.83
MarketCap / Net Operating Revenue (X)3.853.274.201.291.23
Retention Ratios (%)0.0072.6566.0662.4156.66
Price / BV (X)6.855.617.362.062.06
Price / Net Operating Revenue (X)3.853.274.201.291.23
EarningsYield0.020.030.020.060.05

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Amrutanjan Health Care Ltd as of November 19, 2024 is: 706.96

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 19, 2024, Amrutanjan Health Care Ltd is Overvalued by 2.35% compared to the current share price 724.00

Intrinsic Value of Amrutanjan Health Care Ltd as of November 19, 2024 is: 658.99

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 19, 2024, Amrutanjan Health Care Ltd is Overvalued by 8.98% compared to the current share price 724.00

Last 5 Year EPS CAGR: -6.78%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 26.83%, which is a positive sign.
  2. The company has higher reserves (175.46 cr) compared to borrowings (2.31 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (268.85 cr) and profit (44.92 cr) over the years.
  1. The stock has a high average Working Capital Days of 68.00, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 11.50, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Amrutanjan Health Care Ltd:
    1. Net Profit Margin: 9.43%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 23.87% (Industry Average ROCE: 16.25%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 16.77% (Industry Average ROE: 16.45%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 43.91
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.15
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 44 (Industry average Stock P/E: 43.9)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Amrutanjan Health Care Ltd. is a Public Limited Listed company incorporated on 09/09/1936 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1936PLC000017 and registration number is 000017. Currently Company is involved in the business activities of Manufacture of fruit or vegetable juices and their concentrates, squashes and powder. Company’s Total Operating Revenue is Rs. 405.84 Cr. and Equity Capital is Rs. 2.92 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsNo.103 (Old No.42-45), Chennai (Madras) Tamil Nadu 600004shares@amrutanjan.com
http://www.amrutanjan.com
Management
NamePosition Held
Mr. S Sambhu PrasadChairman & Managing Director
Mr. G RaghavanNon Executive Director
Ms. Ramaa Prabhakar ArikirevulaNon Executive Director
Ms. Meenalochani RaghunathanInd. Non-Executive Director
Mr. Raja VenkataramanInd. Non-Executive Director
Mr. S MuralidharanInd. Non-Executive Director

FAQ

What is the latest intrinsic value of Amrutanjan Health Care Ltd?

The latest intrinsic value of Amrutanjan Health Care Ltd as on 19 November 2024 is ₹706.96, which is 2.35% lower than the current market price of ₹724.00.

What is the Market Cap of Amrutanjan Health Care Ltd?

The Market Cap of Amrutanjan Health Care Ltd is 2,090 Cr..

What is the current Stock Price of Amrutanjan Health Care Ltd as on 19 November 2024?

The current stock price of Amrutanjan Health Care Ltd as on 19 November 2024 is ₹724.

What is the High / Low of Amrutanjan Health Care Ltd stocks in FY 2024?

In FY 2024, the High / Low of Amrutanjan Health Care Ltd stocks is 863/556.

What is the Stock P/E of Amrutanjan Health Care Ltd?

The Stock P/E of Amrutanjan Health Care Ltd is 44.0.

What is the Book Value of Amrutanjan Health Care Ltd?

The Book Value of Amrutanjan Health Care Ltd is 103.

What is the Dividend Yield of Amrutanjan Health Care Ltd?

The Dividend Yield of Amrutanjan Health Care Ltd is 0.64 %.

What is the ROCE of Amrutanjan Health Care Ltd?

The ROCE of Amrutanjan Health Care Ltd is 21.3 %.

What is the ROE of Amrutanjan Health Care Ltd?

The ROE of Amrutanjan Health Care Ltd is 15.5 %.

What is the Face Value of Amrutanjan Health Care Ltd?

The Face Value of Amrutanjan Health Care Ltd is 1.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Amrutanjan Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE